
BioCam develops and manufactures an AI-powered capsule endoscopy system for gastrointestinal observation. Their offering includes an endoscopic capsule for imaging and a proprietary AI-powered telemedicine platform and mobile application for real-time threat detection. The system aims to be safe, non-invasive, and patient-friendly, allowing home use with remote physician monitoring. The company highlights up to 97% accuracy in detecting potential pathologies with its AI algorithms and a four-fold increase in image resolution. BioCam has received recognition for innovation, including awards like 'innowacyjny lider 2024' and a 2nd place at Carpathian Startup Fest 2024.

BioCam develops and manufactures an AI-powered capsule endoscopy system for gastrointestinal observation. Their offering includes an endoscopic capsule for imaging and a proprietary AI-powered telemedicine platform and mobile application for real-time threat detection. The system aims to be safe, non-invasive, and patient-friendly, allowing home use with remote physician monitoring. The company highlights up to 97% accuracy in detecting potential pathologies with its AI algorithms and a four-fold increase in image resolution. BioCam has received recognition for innovation, including awards like 'innowacyjny lider 2024' and a 2nd place at Carpathian Startup Fest 2024.
Product: AI-powered capsule endoscopy system (imaging capsule + AI telemedicine platform)
Founded: 2020
Headquarters: Wrocław, Poland
Founders: Maciej Wysocki; Marek Langner; Robert Stachurski
Total funding (reported): 3,956,086 USD
Gastrointestinal diagnostics; non-invasive endoscopic imaging and remote monitoring
2020
Biotechnology
Most recent recorded round on company financial records
“Level2 Ventures; Dawid Ubran; multiple investors including public and private backers listed”